Modulation of Biological Membranes Using Small-Molecule Compounds to Counter Toxicity Caused by Amyloidogenic...

Area of Science:

• Biochemistry
• Molecular Biology
• Neuroscience

Background:

• Protein-misfolding disorders (PMDs) like Alzheimer's, Parkinson's, and type-2 diabetes involve protein aggregation.
• The interaction between misfolded proteins and biological membranes is crucial for disease pathogenesis and cytotoxicity.
• Current treatments primarily focus on anti-aggregation strategies, with limited success.

Purpose of the Study:

• To review the critical role of phospholipid membranes in amyloid pathogenicity.
• To propose a novel therapeutic approach targeting membrane properties in PMDs.
• To explore small molecules that can enhance membrane resilience against misfolded proteins.

Main Methods:

• Literature review focusing on the interplay between misfolded proteins and cell membranes.
• Analysis of existing data on the mechanisms of amyloid formation and cytotoxicity.
• Discussion of potential therapeutic agents that modify membrane physicochemical properties.

Main Results:

• Phospholipid membranes are central to the formation and toxicity of amyloid species.
• Anti-aggregation strategies have limitations in addressing the membrane's role.
• Small molecules can potentially alter membrane properties to counteract protein damage.

Conclusions:

• Modifying membrane properties presents a promising, novel therapeutic avenue for PMDs.
• Natural compounds like aminosterols, cholesterol, and polyphenols show potential in inhibiting amyloid-lipid interactions.
• Targeting the membrane offers a strategy to combat diverse toxic biomolecules in amyloid pathologies.